![]() | Up a level |
Villa, Giovanni, Abdullahi, Adam ORCID: 0000-0001-9703-8264, Owusu, Dorcas, Smith, Colette, Azumah, Marilyn, Sayeed, Laila, Austin, Harrison, Awuah, Dominic, Beloukas, Apostolos
ORCID: 0000-0001-5639-0528, Chadwick, David et al (show 2 more authors)
(2020)
Determining virological suppression and resuppression by point-of-care viral load testing in a HIV care setting in sub-Saharan Africa.
EClinicalMedicine, 18.
100231-.
Abdullahi, Adam ORCID: 0000-0001-9703-8264
(2020)
HIV TREATMENT SIMPLIFICATION: OUTCOMES OF
SWITCHING HIV-1 PATIENTS TO PROTEASE-INHIBITOR
MAINTENANCE MONOTHERAPY.
PhD thesis, University of Liverpool.
Abdullahi, Adam ORCID: 0000-0001-9703-8264, Fopoussi, Olga Mafotsing, Torimiro, Judith, Atkins, Mark, Kouanfack, Charles and Geretti, Anna Maria
ORCID: 0000-0002-3670-6588
(2018)
Hepatitis B Virus (HBV) Infection and Re-activation During Nucleos(t)ide Reverse Transcriptase Inhibitor-Sparing Antiretroviral Therapy in a High-HBV Endemicity Setting.
OPEN FORUM INFECTIOUS DISEASES, 5 (10).
ofy251-.
Abdullahi, Adam ORCID: 0000-0001-9703-8264, Fopoussi, Olga Mafotsing, Torimiro, Judith, Atkins, Mark, Kouanfack, Charles and Geretti, Anna Maria
ORCID: 0000-0002-3670-6588
(2019)
Hepatitis B Virus (HBV) Infection and Re-activation During Nucleos(t)ide Reverse Transcriptase Inhibitor-Sparing Antiretroviral Therapy in a High-HBV Endemicity Setting (vol 5, ofy251, 2018).
OPEN FORUM INFECTIOUS DISEASES, 6 (4).
ofz142-.
Villa, Giovanni, Owusu, Dorcas, Smith, Colette, Azumah, Marilyn, Abdullahi, Adam, Phillips, Suzannah, Sayeed, Laila, Austin, Harrison, Chadwick, David, Phillips, Richard Odame et al (show 1 more authors)
(2022)
Liver steatosis and fibrosis in people with human immunodeficiency virus in West Africa and the relationship with hepatitis B virus coinfection.
HEPATOLOGY COMMUNICATIONS, 6 (11).
pp. 3036-3051.
Abdullahi, Adam, Beloukas, Apostolos ORCID: 0000-0001-5639-0528, Fopoussi, Olga Mafotsing, Torimiro, Judith, Kouanfack, Charles and Geretti, Anna M
ORCID: 0000-0002-3670-6588
(2017)
Risk of hepatitis B virus (HBV) infection and re-activation after discontinuation of tenofovir and/or lamivudine as part of antiretroviral therapy in a high HBV endemicity setting.
, 2017-11-20 - 2017-11-24.
Geretti, Anna Maria ORCID: 0000-0002-3670-6588, Abdullahi, Adam
ORCID: 0000-0001-9703-8264, Fopoussi, Olga Mafotsing, Bonnett, Laura
ORCID: 0000-0002-6981-9212, Defo, Victoire Fokom, Moudourou, Sylvie, Fokam, Joseph, Kouanfack, Charles and Torimiro, Judith
(2019)
An apparent paradox: resistance mutations in HIV-1 DNA predict improved virological responses to antiretroviral therapy.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 74 (10).
pp. 3011-3015.